收入
成本
利润
| Item | Category | Value | YoY |
|---|---|---|---|
| Net operating revenues | revenue | 5.37B | 2.78% |
| Other non-operating income, net | revenue | 41.00M | 57.69% |
| Operating income | profit | 1.30B | 37.43% |
| Salaries, wages and benefits | cost | 2.17B | 2.60% |
| Other operating expenses, net | cost | 1.12B | 2.94% |
| Supplies | cost | 961.00M | 5.95% |
| Depreciation and amortization | cost | 229.00M | 11.17% |
| Litigation and investigation costs | cost | 27.00M | 58.82% |
| Impairment and restructuring charges, and acquisition-related costs | cost | 24.00M | 26.32% |
| Aggregate | revenue | 1.34B | 37.98% |
| Income before income taxes | profit | 1.13B | 47.97% |
| Interest expense, nonoperating | cost | 205.00M | 0.49% |
| Net income | profit | 906.00M | 45.66% |
| Income tax expense | cost | 226.00M | 58.04% |
| Net income available to tenet healthcare corporation common shareholders | profit | 702.00M | 72.91% |
| Less: net income available to noncontrolling interests | cost | 204.00M | -5.56% |
| Segment | Value | YoY |
|---|---|---|
| Hospital Operations | 4.05B | 0.47% |
| Ambulatory Care | 1.32B | 10.55% |
| Segment | Value | YoY |
|---|---|---|
| Health Care, Patient Service | 1.27B | 10.76% |
| Health Care - Other Sources | 54.00M | 5.88% |
| Others | 4.05B | 0.47% |
| Item | Category | Value | YoY |
|---|---|---|---|
| Cash and cash equivalents | assets | 2.97B | |
| Accounts receivable | assets | 2.60B | |
| Other current assets | assets | 2.38B | |
| Inventories of supplies, at cost | assets | 343.00M | |
| Assets held for sale | assets | 62.00M | |
| Total current assets | assets | 8.36B | |
| Goodwill | assets | 11.39B | |
| Property and equipment, at cost, less accumulated depreciation and amortization ($6,814 at march 31, 2026 and $6,680 at december 31, 2025) | assets | 6.25B | |
| Investments and other assets | assets | 3.81B | |
| Net book value | assets | 1.32B | |
| Deferred income taxes | assets | 84.00M | |
| Assets | assets | 31.20B | |
| Total liabilities | liabilities | 22.35B | |
| Total equity | liabilities | 6.71B | |
| Redeemable noncontrolling interests in equity of consolidated subsidiaries | liabilities | 2.14B | |
| Long-term debt and lease obligation | liabilities | 13.13B | |
| Total current liabilities | liabilities | 6.15B | |
| Other long-term liabilities | liabilities | 1.69B | |
| Professional and general liability reserves | liabilities | 938.00M | |
| Defined benefit plan obligations | liabilities | 243.00M | |
| Deferred income taxes | liabilities | 199.00M | |
| Noncontrolling interests | liabilities | 1.90B | |
| Treasury stock, common, value | equity | 5.26B | |
| Accumulated other comprehensive loss | equity | 179.00M | |
| Total shareholders’ equity | equity | 4.81B | |
| Other current liabilities | liabilities | 3.08B | |
| Accounts payable | liabilities | 1.34B | |
| Accrued compensation and benefits | liabilities | 854.00M | |
| Professional and general liability reserves | liabilities | 303.00M | |
| Accrued interest payable | liabilities | 256.00M | |
| Income tax payable | liabilities | 236.00M | |
| Current portion of long-term debt | liabilities | 81.00M | |
| Aggregate | equity | 10.25B | |
| Additional paid-in capital | equity | 5.12B | |
| Retained earnings | equity | 5.12B | |
| Common stock, value, issued | equity | 8.00M |
| Item | Value |
|---|---|
| Net income | 906.00M |
| Increase (decrease) in inventories and other assets, current | 407.00M |
| Increase (decrease) in income taxes receivable | 259.00M |
| Depreciation and amortization | 229.00M |
| Income (loss) from equity method investments, net of dividends or distributions | 29.00M |
| Gain (loss) from litigation settlement | 27.00M |
| Stock-based compensation expense | 25.00M |
| Impairment and restructuring charges, and acquisition-related costs | 24.00M |
| Amortization of debt discount and debt issuance costs | 5.00M |
| Other noncash income (expense) | 2.00M |
| Net losses on sale, consolidation, and deconsolidation of facilities | -1.00M |
| Gain (loss) on disposition of assets | -1.00M |
| Increase (decrease) in accounts receivable | -28.00M |
| Deferred income tax expense (benefit) | -40.00M |
| Payments for restructuring and litigation costs | -57.00M |
| Accounts payable, accrued expenses and other current liabilities | -145.00M |
| Item | Value |
|---|---|
| Proceeds from sales of marketable securities and long-term investments | 22.00M |
| Proceeds from sales of facilities and other assets | 2.00M |
| Payment for (proceeds from) other investing activity | -14.00M |
| Payments to acquire investments | -26.00M |
| Cash paid, net of cash acquired | -121.00M |
| Payments to acquire property, plant, and equipment | -180.00M |
| Item | Value |
|---|---|
| Proceeds from borrowings | 14.00M |
| Proceeds from the sale of noncontrolling interests | 6.00M |
| Repayments of debt | -33.00M |
| Other items, net | -77.00M |
| Payment, tax withholding, share-based payment arrangement | -86.00M |
| Payments of ordinary dividends, noncontrolling interest | -197.00M |
| Payments for repurchase of common stock | -318.00M |
| Payments to noncontrolling interests | -549.00M |
| Item | Value |
|---|---|
| Cash and cash equivalents, beginning of period | 2.88B |
| Cash and cash equivalents, end of period | 2.97B |
快速穿透 10-K/10-Q 复杂数据。通过利润表及资产负债表桑基图，与现金流量表瀑布图，一站式洞悉企业财务流向。
在左侧搜索公司并选择一份报告。
申请股票支持